These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16305403)

  • 1. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization.
    Sinha VR; Agrawal MK; Kumria R
    Curr Drug Deliv; 2005 Jan; 2(1):1-8. PubMed ID: 16305403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM; Heng PW
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A; Vetchý D; Janovská L; Krejcová K; Rabisková M
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of starting material particle size on pellet surface roughness.
    Sarkar S; Ang BH; Liew CV
    AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F; Knight P
    Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of the extrusion die on pellet characteristics.
    Rabisková M; Weingartová D; Häring A
    Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two commercial brands of microcrystalline cellulose for extrusion-spheronization.
    Law MF; Deasy PB; McLaughlin JP; Gabriel S
    J Microencapsul; 1997; 14(6):713-23. PubMed ID: 9394252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-emulsifying Pellets Prepared by Extrusion/Spheronization: In vitro/In vivo Evaluation.
    Rahman MA; Mujahid M; Hussain A
    Recent Pat Drug Deliv Formul; 2016; 10(3):245-252. PubMed ID: 27774911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of starch-based pellets via extrusion/spheronisation.
    Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW; Koo OM
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):451-6. PubMed ID: 12056538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.